Saudi Food and Drug Authority - Regulatory authority for pharmaceuticals and medical devices in Saudi Arabia
显示 2021 年的审批记录
仅限当前页。暂不支持搜索完整审批数据集。
药物名称 | 公司 | 适应症 | 日期 | 类型 |
|---|---|---|---|---|
| REVANESSE CONTOUR | Prollenium Medical Technologies | Injection | Jan 1, 2021 | Generic |
| CLARIDAR XL 500 mg Tablet | DAR ALDAWA | Prolonged-release tablet | Jan 1, 2021 | Generic |
| REVANESSE PURE | Prollenium Medical Technologies | Injection | Jan 1, 2021 | Generic |
| Dandaxa | GULF PHARMACEUTICAL INDUSTIRES- JULPHAR | Film-coated tablet | Jan 1, 2021 | Generic |
| NEGAZOLE | GULF PHARMACEUTICAL INDUSTIRES- JULPHAR | Film-coated tablet | Jan 1, 2021 | Generic |
| Kanvasiv | HIKMA ITALIA SPA | Powder for concentrate for solution for infusion | Jan 1, 2021 | Generic |
| REVANESSE KISS | Prollenium Medical Technologies | Injection | Jan 1, 2021 | Generic |
| REVANESSE ULTRA | Prollenium Medical Technologies | Injection | Jan 1, 2021 | Generic |
| Zoxta | Savvy Pharma | Film-coated tablet | Jan 1, 2021 | Generic |
| TiboFem | CENEXI | Tablet | Jan 1, 2021 | Generic |
| Batlor | BATTERJEE PHARMACETICAL FACTORY | Syrup | Jan 1, 2021 | Generic |
| Decryst | Jazeera Pharmaceutical Industries (JPI) | Film-coated tablet | Jan 1, 2021 | Generic |
| Trexon | EIPICO | Powder and solvent for solution for injection | Jan 1, 2021 | Generic |
| Ultomiris 300 mg/30 mL | Alexion Pharma International Operations Unlimited Company | Concentrate for solution for infusion | Jan 1, 2021 | Biological |
| Doptelet | Kawashima Plant, Eisai Co., Ltd | Film-coated tablet | Jan 1, 2021 | NCE |
| Megmento | Hikma Farmaceutica | Powder for solution for infusion | Jan 1, 2021 | Generic |
| TERODA | SPIMACO | Tablet | Jan 1, 2021 | Generic |
| Darzalex 1800 mg per 15 ml | JANSSEN-CILAG | Solution for injection | Jan 1, 2021 | Biological |
| EPITAM 1000MG F.C.TAB | Jazeera Pharmaceutical Industries (JPI) | Film-coated tablet | Jan 1, 2021 | Generic |
| Lenamid | Hetero Labs Limited Unit – III | Capsule, hard | Jan 1, 2021 | Generic |
